vs
Side-by-side financial comparison of Dexcom (DXCM) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.2× Everus Construction Group, Inc.). Dexcom runs the higher net margin — 21.2% vs 5.5%, a 15.8% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 21.6%). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
DXCM vs ECG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.0B |
| Net Profit | $267.3M | $55.3M |
| Gross Margin | 62.9% | 11.6% |
| Operating Margin | 25.6% | 6.8% |
| Net Margin | 21.2% | 5.5% |
| Revenue YoY | 21.6% | 33.2% |
| Net Profit YoY | 153.6% | 60.4% |
| EPS (diluted) | $0.67 | $1.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.0B | ||
| Q3 25 | $1.2B | $986.8M | ||
| Q2 25 | $1.2B | $921.5M | ||
| Q1 25 | $1.0B | $826.6M | ||
| Q4 24 | $1.1B | $759.6M | ||
| Q3 24 | $994.2M | $761.0M | ||
| Q2 24 | $1.0B | $703.4M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $55.3M | ||
| Q3 25 | $283.8M | $57.0M | ||
| Q2 25 | $179.8M | $52.8M | ||
| Q1 25 | $105.4M | $36.7M | ||
| Q4 24 | $151.7M | $34.5M | ||
| Q3 24 | $134.6M | $41.8M | ||
| Q2 24 | $143.5M | $39.0M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 11.6% | ||
| Q3 25 | 60.5% | 12.6% | ||
| Q2 25 | 59.5% | 13.0% | ||
| Q1 25 | 56.9% | 11.2% | ||
| Q4 24 | 58.9% | 11.4% | ||
| Q3 24 | 59.7% | 11.8% | ||
| Q2 24 | 62.4% | 12.6% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 6.8% | ||
| Q3 25 | 20.1% | 7.3% | ||
| Q2 25 | 18.4% | 7.9% | ||
| Q1 25 | 12.9% | 6.2% | ||
| Q4 24 | 17.0% | 6.1% | ||
| Q3 24 | 15.3% | 7.1% | ||
| Q2 24 | 15.7% | 7.3% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 5.5% | ||
| Q3 25 | 23.5% | 5.8% | ||
| Q2 25 | 15.5% | 5.7% | ||
| Q1 25 | 10.2% | 4.4% | ||
| Q4 24 | 13.6% | 4.5% | ||
| Q3 24 | 13.5% | 5.5% | ||
| Q2 24 | 14.3% | 5.5% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.09 | ||
| Q3 25 | $0.70 | $1.11 | ||
| Q2 25 | $0.45 | $1.03 | ||
| Q1 25 | $0.27 | $0.72 | ||
| Q4 24 | $0.37 | $0.68 | ||
| Q3 24 | $0.34 | $0.82 | ||
| Q2 24 | $0.35 | $0.76 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | $281.5M |
| Stockholders' EquityBook value | $2.7B | $629.8M |
| Total Assets | $6.3B | $1.7B |
| Debt / EquityLower = less leverage | — | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | $553.0K | ||
| Q2 24 | $939.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $281.5M | ||
| Q3 25 | — | $285.1M | ||
| Q2 25 | — | $288.6M | ||
| Q1 25 | — | $292.1M | ||
| Q4 24 | — | $295.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $629.8M | ||
| Q3 25 | $2.7B | $573.0M | ||
| Q2 25 | $2.6B | $514.4M | ||
| Q1 25 | $2.3B | $460.2M | ||
| Q4 24 | $2.1B | $422.6M | ||
| Q3 24 | $2.0B | $453.3M | ||
| Q2 24 | $2.4B | $490.0M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $1.7B | ||
| Q3 25 | $7.5B | $1.6B | ||
| Q2 25 | $7.3B | $1.5B | ||
| Q1 25 | $6.8B | $1.4B | ||
| Q4 24 | $6.5B | $1.3B | ||
| Q3 24 | $6.4B | $1.3B | ||
| Q2 24 | $6.8B | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | — | 0.56× | ||
| Q1 25 | — | 0.63× | ||
| Q4 24 | — | 0.70× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $48.2M |
| Free Cash FlowOCF − Capex | — | $23.5M |
| FCF MarginFCF / Revenue | — | 2.3% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.87× |
| TTM Free Cash FlowTrailing 4 quarters | — | $90.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $48.2M | ||
| Q3 25 | $659.9M | $76.2M | ||
| Q2 25 | $303.0M | $25.3M | ||
| Q1 25 | $183.8M | $7.1M | ||
| Q4 24 | $301.4M | — | ||
| Q3 24 | $199.5M | $78.9M | ||
| Q2 24 | $279.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $23.5M | ||
| Q3 25 | $579.4M | $65.7M | ||
| Q2 25 | $208.9M | $12.3M | ||
| Q1 25 | $96.8M | $-11.4M | ||
| Q4 24 | $176.8M | — | ||
| Q3 24 | $88.3M | $60.9M | ||
| Q2 24 | $213.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 2.3% | ||
| Q3 25 | 47.9% | 6.7% | ||
| Q2 25 | 18.1% | 1.3% | ||
| Q1 25 | 9.3% | -1.4% | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 8.9% | 8.0% | ||
| Q2 24 | 21.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 2.4% | ||
| Q3 25 | 6.7% | 1.1% | ||
| Q2 25 | 8.1% | 1.4% | ||
| Q1 25 | 8.4% | 2.2% | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 11.2% | 2.4% | ||
| Q2 24 | 6.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 0.87× | ||
| Q3 25 | 2.33× | 1.34× | ||
| Q2 25 | 1.69× | 0.48× | ||
| Q1 25 | 1.74× | 0.19× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | 1.89× | ||
| Q2 24 | 1.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
ECG
| Commercial | $594.5M | 59% |
| Utility | $203.5M | 20% |
| Industrial | $82.8M | 8% |
| Institutional | $66.1M | 7% |
| Service And Other | $28.4M | 3% |
| Transportation | $24.2M | 2% |
| Renewables | $19.8M | 2% |
